MedTrace Logo

Physical Performance Testing and Frailty in Prediction of Early Postoperative Course After Cardiac Surgery

NCT05166863 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-05-08

No results posted yet for this study

Summary

Standard risk prediction models in cardiac surgery (such as EuroSCORE II or STS score) are designed to analyze solely the risk of short-term postoperative mortality. The postoperative morbidity, the ability to rehabilitate or the mid-term survival are not addressed by these means. Recently there have been some reports that addition of physical performance testing to the standard prediction models may provide prognostic value. There is a wide scale of various physical performance and frailty tests that could be used for this purpose, but they have not been confronted with each other yet. Moreover, the postoperative physical rehabilitation has not been objectively assessed in larger scale despite the significant improvement in technology.

The hypothesisis of the study is that the preoperative outcomes of physical performance and frailty testing are able to predict the patient's reconvalescence after cardiac surgery in the short- and mid-term postoperatively. The aim is to analyze a set of tests with regard to their ability to predict postoperative reconvalescence, including the objective activity assessment (using Actigraph wGT3X-BT activity tracking device). Secondarily, the investigators aim to follow the patients up to 1 year postoperatively in terms of evaluating their mid-term outcomes.

Conditions

  • Cardiac Surgery
  • Rehabilitation
  • Frailty
  • Physical Performance

Sponsors & Collaborators

  • Charles University, Czech Republic

    collaborator OTHER

  • Jan Gofus, MD, PhD

    lead OTHER

Principal Investigators

  • Ján Gofus, MD, PhD · University Hospital Hradec Králové

  • Jan Vojáček, Professor, MD, PhD · University Hospital Hradec Králové

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-29
Primary Completion
2023-12-30
Completion
2024-12-30

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05166863 on ClinicalTrials.gov